The most documented agent for allodynia, with published case series and epidemiological data
2023 Nov 28;82(22):2087-2096
This study offers a practical guideline for surgeons managing patients on GLP-1 agonists in the perioperative period for lower extremity THA and TKA procedures
There were 2 additional cases in SAXENDA-treated patients, 1 during an off-treatment follow-up period within 2 weeks of discontinuing SAXENDA, and 1 that occurred in a patient who completed treatment and was off-treatment for 106 days
Compounded drugs administered in the inpatient setting will not be reimbursed, as they will be bundled into a diagnosis-related group payment
Related: Natural Sweetener Boosts a Common Treatment For Hair Loss, Study Reveals That doesn't mean this is something that can be ignored but it also means that for many it might still be worth the help with weight loss and type 2 diabetes management that these GLP-1 drugs bring